Abstract
This article focuses on the ability of dendritic molecules to interact with nucleic acids and hence deliver them into cells. Dendritic molecules have branched structures which are made by an iterative, layer-by-layer synthesis. The control applied in their synthesis means that dendrimers are well-defined nanoscale molecular species - ideal for interacting with nanoscale bio-targets such as DNA/RNA. Binding and delivery of genetic material into cells in vivo holds out the prospect of gene therapy, and we will consider the potential advantages of dendritic vectors in this field of nanomedicine. As this article illustrates, the synthetic versatility of dendritic molecules has enabled the synthesis of a wide array of DNA binders and delivery vehicles, with different advantages. This versatility forms the basis for optimism that the dendritic approach may well yield active, highly targeted delivery vectors, suitable for in vivo application in gene therapy
Keywords: Dendrimers and dendrons, DNA, gene therapy, siRNA, vectors
Current Topics in Medicinal Chemistry
Title: Dendrimers and the Double Helix - From DNA Binding Towards Gene Therapy
Volume: 8 Issue: 14
Author(s): David K. Smith
Affiliation:
Keywords: Dendrimers and dendrons, DNA, gene therapy, siRNA, vectors
Abstract: This article focuses on the ability of dendritic molecules to interact with nucleic acids and hence deliver them into cells. Dendritic molecules have branched structures which are made by an iterative, layer-by-layer synthesis. The control applied in their synthesis means that dendrimers are well-defined nanoscale molecular species - ideal for interacting with nanoscale bio-targets such as DNA/RNA. Binding and delivery of genetic material into cells in vivo holds out the prospect of gene therapy, and we will consider the potential advantages of dendritic vectors in this field of nanomedicine. As this article illustrates, the synthetic versatility of dendritic molecules has enabled the synthesis of a wide array of DNA binders and delivery vehicles, with different advantages. This versatility forms the basis for optimism that the dendritic approach may well yield active, highly targeted delivery vectors, suitable for in vivo application in gene therapy
Export Options
About this article
Cite this article as:
Smith K. David, Dendrimers and the Double Helix - From DNA Binding Towards Gene Therapy, Current Topics in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/156802608785849030
DOI https://dx.doi.org/10.2174/156802608785849030 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Natural Product Photoantimicrobials
Current Bioactive Compounds The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
Current Cancer Therapy Reviews Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets Network Propagation Reveals Novel Features Predicting Drug Response of Cancer Cell Lines
Current Bioinformatics Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling
Current Angiogenesis (Discontinued) Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Anti-Cancer Agents in Medicinal Chemistry Preparation and Preliminary Evaluation of <sup>68</sup>Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging
Anti-Cancer Agents in Medicinal Chemistry Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Recent Patents on DNA & Gene Sequences False Positive of <sup>68</sup>Ga-DOTATATE PET-CT in a Paraganglioma
Endocrine, Metabolic & Immune Disorders - Drug Targets Design, Synthesis and Antiproliferative Activity of 2-Acetamidothiazole-5- carboxamide Derivatives
Medicinal Chemistry MicroRNAs as Therapeutic Agents: The Future of the Battle Against Cancer
Current Topics in Medicinal Chemistry Clonetics
Current Drug Metabolism Aging and Inflammation: Etiological Culprits of Cancer
Current Aging Science 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors
Anti-Cancer Agents in Medicinal Chemistry A Structural Insight into Hydroxamic Acid Based Histone Deacetylase Inhibitors for the Presence of Anticancer Activity
Current Medicinal Chemistry Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
Current Drug Targets Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Current Cancer Drug Targets